Uplizd Biologics R&D
Uplizd Biopharma R&D: Traceable scientific AI workspace.
Details
- Target Audience
- Small BusinessesStartups
- Pricing
- Freemium from $17
- Platforms
- Web
About Uplizd Biologics R&D
Uplizd is an enterprise multi-agent AI platform tailored for biopharmaceutical R&D. It accelerates sequence-aware analysis, scientific retrieval, and experiment planning by deploying specialized agents for parallel tasks like liability scanning and literature cross-referencing. Designed to keep scientists in control, Uplizd delivers fully reviewable results with explicit citations and end-to-end provenance in a unified workspace. Built for regulated environments, it features ~3.3-second processing per sequence, native integrations (FASTA, PubMed, Slack), immutable audit logs, RBAC, and flexible deployment (Cloud or On-prem) to ensure strict traceability and governance.
Product Insights
Uplizd Biologics R&D provides a specialized multi-agent AI workspace for biopharma operations with a fokus on sequence analysis and automated documentation. It bridges specialized scientific retrieval with enterprise-grade security for small businesses and startups working in regulated environments.
- Advanced traceability with immutable audit logs, RBAC, and end-to-end provenance for regulatory compliance.
- High-speed performance featuring roughly 3.3-second processing per sequence for rapid liability scanning.
- Flexible deployment options including Web, Cloud, or On-prem to meet diverse biopharmaceutical infrastructure needs.
- Deep integrations with scientific and communication tools like PubMed, FASTA, and Slack.
Ideal for: Small businesses and startups in the biopharmaceutical sector require this platform to automate experiment planning and sequence analysis while maintaining strict audit trails.
Screenshots
Reviews (0)
No reviews yet. Be the first to rate this product!
Comments (0)
No comments yet. Be the first to share your thoughts!